Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
about
Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stabilityThe Fanconi anemia pathway and ubiquitinVeliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.tRNA modifications regulate translation during cellular stress.Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancersIdentification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells.Fanconi anaemia genes and susceptibility to cancer.The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma.Helicases as prospective targets for anti-cancer therapy.Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.Fanconi anaemia: from a monogenic disease to sporadic cancer.Biomarkers and mechanisms of FANCD2 functionInhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway.5-Aza-2'-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair.Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditionsCisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival.Fanconi anemia: a paradigm of discovering molecular pathways from patients.A molecular bar-coded DNA repair resource for pooled toxicogenomic screens.Fanconi anemia repair pathway dysfunction, a potential therapeutic target in lung cancerLow incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer.Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.Unraveling the role of FANCD2 in chronic myeloid leukemia
P2860
Q28509626-3BDCF837-59DA-4C45-AFE9-438ED38B296BQ28756516-9F3B0944-ACE7-4138-A688-A8EBBDBBA77CQ33429801-13E690E1-95D1-4215-A8DD-1BCEAE2839BCQ33784347-5C407626-42FD-4F5D-91BC-457E4CF1FBCCQ35490491-F1E66839-8087-4319-9832-B8F7441AB479Q35951292-A948FF3E-469B-41A7-B298-38A9CF370E2EQ36301178-D835CB36-F50C-412B-BE29-33F7646FDBDFQ36458938-AEE33A61-11D9-4566-8037-BA3A3F3D1605Q36602573-DE1CB21E-D48E-42E8-B176-80604C80BB96Q36867985-43A042D3-BD88-4767-B70A-3D7A93414426Q36930862-4F815EDA-9A28-407B-B3A7-EE488115FF08Q37069628-63F333EC-9C2F-4C8F-8233-A74EE1AFC2EAQ37128839-B9DBE999-77AA-4054-B37D-A98A060610B8Q37865169-90A9DF6B-B64B-438C-8EE1-BC08BC5CFCF5Q38287129-DDFD3D70-C3AA-43A9-B2C0-0617FDBD11A5Q39111478-EA7FC642-0B02-453A-81CE-D3E1A867EAC0Q39162136-AF7EAE26-8CD6-4E0B-B1E9-28F2301661D2Q39210775-5F9DAB00-CE12-40FA-BE16-2693338B9D77Q39847548-636B0A5E-2978-451C-B0EA-CA8A2FD21280Q39858700-0CA08AC0-8E37-44B9-BD48-D496558F6EE3Q41809959-0C73BB2C-5E0B-4CF1-B7C5-E64FF2B510FCQ41830209-73B848CD-827B-4ABA-AB19-30BA09AE10B1Q42021055-7B90765A-94EA-4EB6-931C-692525F73A28Q42461070-C34E3A06-72CA-46D7-B80A-0246F9B1B46CQ52604402-E23AF92A-CAE1-4C5D-947D-734F4F37F639Q57952410-904235C4-E7CB-4BBD-A909-9685FEE72636
P2860
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@ast
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@en
type
label
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@ast
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@en
prefLabel
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@ast
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@en
P1433
P1476
Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer.
@en
P2093
Alex Lyakhovich
P304
P356
10.1016/J.CANLET.2005.07.038
P407
P577
2005-10-21T00:00:00Z